These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23596223)

  • 1. India's rejection of Novartis's patent is but a small step in the right direction.
    Bhaumik S
    BMJ; 2013 Apr; 346():f2412. PubMed ID: 23596223
    [No Abstract]   [Full Text] [Related]  

  • 2. Indian Supreme Court rejects Novartis's appeal on drug patent.
    Arie S
    BMJ; 2013 Apr; 346():f2099. PubMed ID: 23550079
    [No Abstract]   [Full Text] [Related]  

  • 3. Big Pharma vs India’s Patent Office.
    Pharm Pat Anal; 2012 Nov; 1(5):529. PubMed ID: 24236921
    [No Abstract]   [Full Text] [Related]  

  • 4. MSF challenges Novartis's action over Indian patent for imatinib.
    Mudur G
    BMJ; 2007 Jan; 334(7586):172. PubMed ID: 17255582
    [No Abstract]   [Full Text] [Related]  

  • 5. Engineered in India--patent law 2.0.
    Kapczynski A
    N Engl J Med; 2013 Aug; 369(6):497-9. PubMed ID: 23862973
    [No Abstract]   [Full Text] [Related]  

  • 6. India's patent case victory rattles Big Pharma.
    Chatterjee P
    Lancet; 2013 Apr; 381(9874):1263. PubMed ID: 23589911
    [No Abstract]   [Full Text] [Related]  

  • 7. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 8. Supreme Court of India rejects Novartis’ cancer drug patent.
    Heseltine P
    Pharm Pat Anal; 2013 May; 2(3):299-300. PubMed ID: 24237056
    [No Abstract]   [Full Text] [Related]  

  • 9. Will the refusal of patent protection for Glivec® discourage future pharmaceutical innovation in India?
    Albutt J
    Pharm Pat Anal; 2013 Jul; 2(4):439-41. PubMed ID: 24237119
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent watch: Indian Supreme Court blocks Novartis’ Glivec patent.
    Harrison C
    Nat Rev Drug Discov; 2013 May; 12(5):336-7. PubMed ID: 23598506
    [No Abstract]   [Full Text] [Related]  

  • 11. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 12. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
    Moszynski P
    BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes to India's patent law may deny cheap drugs to millions.
    Mudur G
    BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
    [No Abstract]   [Full Text] [Related]  

  • 14. Is India ready to lead the battle for fair access to medicines?
    Lancet Oncology
    Lancet Oncol; 2013 May; 14(6):437. PubMed ID: 23639313
    [No Abstract]   [Full Text] [Related]  

  • 15. India's new patent laws may still hurt generic drug supplies.
    Chatterjee P
    Lancet; 2005 Apr 16-22; 365(9468):1378. PubMed ID: 15841559
    [No Abstract]   [Full Text] [Related]  

  • 16. The Indian Supreme Court's judgment in the case of Glivec(®) - the uncertain future of pharmaceutical patents in India.
    Thikkavarapu PR
    Pharm Pat Anal; 2014 Mar; 3(2):117-9. PubMed ID: 24588585
    [No Abstract]   [Full Text] [Related]  

  • 17. A modest but meaningful decision for Indian drug patents.
    Attaran A
    Lancet; 2014 Aug; 384(9942):477-9. PubMed ID: 24976117
    [No Abstract]   [Full Text] [Related]  

  • 18. [Novartis should discontinue its patent case in India!].
    PehrOlov P
    Lakartidningen; 2007 Feb 14-20; 104(7):524. PubMed ID: 17375688
    [No Abstract]   [Full Text] [Related]  

  • 19. India's decision on Gleevec: implications for the future.
    Wilensky GR
    Healthc Financ Manage; 2013 May; 67(5):32-3. PubMed ID: 23678685
    [No Abstract]   [Full Text] [Related]  

  • 20. In pursuit of patents.
    Huilgol N
    J Cancer Res Ther; 2013; 9(2):177-8. PubMed ID: 23771353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.